AposTherapy® was developed by Dr. Avi Elbaz and Dr. Amit Mor who come from the fields of orthopedics and sports medicine. The development of the treatment began in the 90’s in response to the growing evidence and better understanding of biomechanics and the central role that the neuromuscular system plays in the development and the rehabilitation of orthopedic conditions.
In 2004, the company was incorporated and the first flagship center was opened in Herzliya, Israel, with over 60,000 patients treated worldwide.
In 2015 the company launched a global initiative to offer its technology and treatment through physiotherapy and multi-discipinary centres. AposTherapy® now has multiple partner clinics around the world (US, UK, Israel and Singapore).
AposTherapy® is a personalised program for the treatment of various orthopedic conditions, which utilises an individually calibrated, patent protected, foot-worn biomechanical device. The treatment is delivered by specially-trained physical therapists and is carried out during the patient’s normal daily activities, at home or at work, for about an hour a day to enable optimal results.
The aim of AposTherapy® is to address the biomechanical abnormalities that are characteristic of various orthopaedic conditions – the body’s mal-alignment, muscle weakness, impaired neuromuscular control and the resulted abnormal pathological movement patterns. The ultimate goal of the treatment is to promote and restore desired motor patterns.
Our philosophy is to empower patients by enhancing their understanding of their condition and the underlying causes of their symptoms. This knowledge, combined with a personalised treatment modality, allows the patient to take active control over their therapy and progress. Their progress is closely monitored and clinical outcomes are shared with the patients so they have an objective measurement of their improvement.
The principles of applying a scientific approach to everything we do is at the core of, and instilled into, the very essence of AposTherapy®. To date, we have many collaborative research papers published in independent peer-reviewed journals.
We welcome all opportunities to learn and understand more about the various musculoskeletal diseases and their pathophysiologies, manifestations, and how AposTherapy® and its partners can jointly improve the quality of life of those affected.
“I researched Apostherapy as treatment for my patients, and visited the treatment centre in Central London. I was impressed by the devotion and care to patients. Subsequently many patients that I (and general practice) do not have to offer for joint pain, have referred for an objective assessment -not everyone will benefit, but all the patients are impressed by a thorough investigation.” Dr Martin Harris